Posted in | News | Gold | Mining Business

Advance Metals and Sky Metals Plan Combined Gold Explorer, Targeting $6 m ASX IPO

Advance Metals Limited and Sky Metals Limited have signed a non-binding term sheet to combine their Australian gold project interests into a new company, which will seek admission to the ASX.

Location of the proposed gold exploration portfolio comprising AVM and SKY projects in SE Australia. Image Credit: Advance Metals Limited

The new company would bring together Advance’s Myrtleford and Beaufort Gold Projects in Victoria and SKY’s Cullarin, Kangiara and Caledonian Projects in New South Wales. Together they cover more than 2,000 km2 in the Lachlan Fold Belt and include the high-grade Happy Valley and Hume gold discoveries.

Advance and SKY will transfer their project interests in exchange for 30 million and 15 million shares respectively, at a deemed $0.20 a share. No cash will be paid. These shares are expected to be held in escrow for 24 months from listing. PAC Partners will be lead manager on the targeted $6 million IPO.

“By providing these assets with dedicated management, capital and exploration focus, we believe their potential can be more effectively realized,” said Advance Managing Director and CEO Adam McKinnon.

Sky Metals Managing Director Oliver Davies said the deal would give the projects dedicated funding and a single exploration focus, while SKY concentrates on its core tin-tungsten development portfolio.

The deal still has to clear several conditions, including due diligence, formal agreements, shareholder and regulatory approvals, and ASX approval. The parties aim to satisfy these by March 2027. There is no certainty that the transaction or IPO will proceed.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.